Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.012 | 0.0784 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.1311 | 1 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.012 | 0.0784 | 0.5 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.012 | 0.0784 | 0.5 |
Onchocerca volvulus | CoRest homolog | 0.0669 | 0.5035 | 1 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.012 | 0.0784 | 0.462 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.012 | 0.0784 | 0.5 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.012 | 0.0784 | 0.462 |
Plasmodium vivax | hypothetical protein, conserved | 0.012 | 0.0784 | 1 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.012 | 0.0784 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.012 | 0.0784 | 0.462 |
Loa Loa (eye worm) | hypothetical protein | 0.065 | 0.4888 | 0.9708 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.012 | 0.0784 | 0.462 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.1696 | 0.3369 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0784 | 0.1557 |
Schistosoma mansoni | amine oxidase | 0.012 | 0.0784 | 0.462 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0238 | 0.1696 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0881 | 0.1749 |
Loa Loa (eye worm) | hypothetical protein | 0.0251 | 0.1793 | 0.3562 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0133 | 0.0881 | 0.1802 |
Brugia malayi | hypothetical protein | 0.012 | 0.0784 | 0.1604 |
Onchocerca volvulus | 0.0251 | 0.1793 | 0.3562 | |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.119 | 0.9069 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0669 | 0.5035 | 1 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.065 | 0.4888 | 1 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.012 | 0.0784 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.1696 | 0.3369 |
Plasmodium vivax | hypothetical protein, conserved | 0.012 | 0.0784 | 1 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.012 | 0.0784 | 1 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.012 | 0.0784 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.012 | 0.0784 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.0251 | 0.1793 | 0.3669 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0238 | 0.1696 | 1 |
Leishmania major | UDP-galactopyranose mutase | 0.012 | 0.0784 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.012 | 0.0784 | 0.5 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0238 | 0.1696 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0784 | 0.1557 |
Echinococcus multilocularis | 0.012 | 0.0784 | 0.462 | |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.012 | 0.0784 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Agonist activity at TRPV1 receptor in E15 rat primary dorsal root ganglion cells assessed as effect on 45Ca2+ influx by microplate liquid scintillation counter | ChEMBL. | 18809334 | |
Activity (binding) | Binding affinity to rat adenosine A3 receptor | ChEMBL. | 18809334 | |
Emax (functional) | = 148 % | Agonist-enhancing activity in epsilon-epitope tagged TRPV1 receptor expressed in mouse NIH3T3 cells assessed as capsaicin-induced 45Ca2+ influx at 100 uM by microplate liquid scintillation counter relative to capsaicin alone | ChEMBL. | 18809334 |
Inhibition (binding) | = 2.09 % | Binding affinity towards adenosine A3 receptor by measuring its ability to displace [125I]-AB-MECA binding to membranes prepared from HEK-293 cells | ChEMBL. | 9703464 |
Inhibition (binding) | = 2.09 % | Binding affinity towards adenosine A3 receptor by measuring its ability to displace [125I]-AB-MECA binding to membranes prepared from HEK-293 cells | ChEMBL. | 9703464 |
Inhibition (binding) | = 2.73 % | Binding affinity towards adenosine A3 receptor by [125I]-AB-MECA displacement. | ChEMBL. | 9703464 |
Inhibition (binding) | = 2.73 % | Binding affinity towards adenosine A3 receptor by [125I]-AB-MECA displacement. | ChEMBL. | 9703464 |
Inhibition (binding) | < 10 % | Binding affinity towards adenosine A2A receptor by measuring its ability to displace [3H]-CGS- 21680 in rat striatal membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Inhibition (binding) | < 10 % | Binding affinity towards adenosine A2A receptor by measuring its ability to displace [3H]-CGS- 21680 in rat striatal membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Inhibition (binding) | = 26 % | Binding affinity towards adenosine A1 receptor by measuring its ability to displace [3H]-R-PIA in rat brain membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Inhibition (binding) | = 26 % | Binding affinity towards adenosine A1 receptor by measuring its ability to displace [3H]-R-PIA in rat brain membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Ki (binding) | = 2.09 uM | Binding affinity to human adenosine A3 receptor | ChEMBL. | 18809334 |
Ratio (binding) | > 20 | Selectivity for binding affinity towards A1 adenosine receptor in rat brain membrane and human A3 receptor expressed in HEK cells | ChEMBL. | 9703464 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.